ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0805

Rheumatic Fever and Streptococcal Cutaneous Infection: A Case-control Study in the Loyalty Islands, New Caledonia

Quentin AMIC-DESVAUD1, Olivier MAILLARD2, Sylvia IACOBELLI3, Thomas BARDIN4 and Yves-Marie DUCROT5, 1Province des îles Loyauté, Lifou, New Caledonia, 2Centre Hospitalier Universitaire de la Reunion, Saint-Denis, France, 3Centre Hospitalier Universitaire, Saint Dénis de la Réunion, France, 4Université de Paris, Paris, France, 5Province des îles Loyauté, We, Lifou Island, New Caledonia

Meeting: ACR Convergence 2022

Keywords: autoimmune diseases, Epidemiology, Heart disease, Pediatric rheumatology, Subclinical Cardiovascular Disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Infection-related Rheumatic Disease Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Acute Rheumatic Fever (ARF) and Rheumatic Heart Disease (RHD) remain major public health problems in the South Pacific. Triggering by group A beta hemolytic streptococcal (GAS) skin infection has been suspected but little documented1. Very high incidences of ARF (106/100 000) and cutaneous infections have been reported in the Loyalty islands (New Caledonia), where health care of the 20,000 Melanesian inhabitants is centralized in a few locations and provides an extensive electronic database since 1998, and systematic screening for RHD is regularly performed.

The aims of the study was to explore the link between ARF, RHD and skin infections by a retrospective case-control study.

Methods: The study was approved by the New Caledonian committee of Ethics and dealt with patients aged 6 to 26 years, seen from 1998 to 2018. Cases were ARF and/or RHD. Definite ARF was diagnosed according to the Jones criteria2; additional cases with strong clinical suspicion were also included as probable cases. RHD was diagnosed by cardiac ultrasound scan allowing definite and borderline diagnosis2. Sore throat and presumed streptococcal cutaneous infections were diagnosed by an algorithm, previously validated on a sample of 3000 events by an experimented clinician, which identified specific medical terms and ICD-10 codes in the electronic medical records. Each case was matched with 3 controls (without ARF and RHD) of same age, sex and living location. Infections were retrieved from the electronic medical records during the month, 6 months, one year, 5 years preceding the date of the first ARF/RHD diagnosis, for each case with the same index date for its matched control, and since birth. Numbers of infections per these time intervals were compared between cases and controls by univariate and multivariate conditional regression analysis in the total study population and its various subcategories (definite or probable ARF, definite or borderline RHD).

Results: 311 cases of ARF and RHD including 206 definite cases were identified. Polyarthralgias (48%) were the main clinical presentation. Marginal erythema was not seen and Sydenham chorea was rare (6.8%). Mean age of diagnosis was 10.6 ±3.8 years. Skin infection episodes were 3 to 4 times more frequent than sore throats in all studied time-intervals.

Multivariate analysis showed an increased exposure to skin infections and sore throats in the year preceding ARF/RHD diagnosis in the whole population of cases as compared to controls ( OR 2.18, 95% CI 1.46, 3.26) and 1.54, 95% CI 1.01, 2.36] respectively); skin infections (but not sore throat) were also increased the 206 definite cases (OR 1.34, 95% CI 1.01, 1.80) and in the 220 definite and probable ARF (OR 1.47, 95% CI 1.11, 1.94). In addition we observed a correlation between the seasonality of ARF and skin infections, which were both more frequent during the rainy season, and an overlap of areas with high incidence of ARF and areas with high incidence of skin infections.

Conclusion: Our results support the hypothesis that GAS skin infections play a role in the pathophysiology of ARF/RHD. In view of these results, there is an urgent need to implement preventive measures to reduce the incidence of skin infections in the Loyalty Islands.


Disclosures: Q. AMIC-DESVAUD, None; O. MAILLARD, None; S. IACOBELLI, None; T. BARDIN, None; Y. DUCROT, None.

To cite this abstract in AMA style:

AMIC-DESVAUD Q, MAILLARD O, IACOBELLI S, BARDIN T, DUCROT Y. Rheumatic Fever and Streptococcal Cutaneous Infection: A Case-control Study in the Loyalty Islands, New Caledonia [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/rheumatic-fever-and-streptococcal-cutaneous-infection-a-case-control-study-in-the-loyalty-islands-new-caledonia/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatic-fever-and-streptococcal-cutaneous-infection-a-case-control-study-in-the-loyalty-islands-new-caledonia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology